Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gyan

Showing results (131-140 of 174) with videos related to

Pageof 18
Sort By:
Haematologica|February 9, 2019
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failureMarie Sébert, Aline Renneville, Cécile Bally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized TrialsQian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.
Blood|May 24, 2015
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosisStéphane Barete, Olivier Lortholary, Gandhi Damaj, et al.
The Lancet. Haematology|December 22, 2015
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trialAntonio Omuro, Olivier Chinot, Luc Taillandier, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Haematologica|October 3, 2015
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective studyJulien Lazarovici, Peggy Dartigues, Pauline Brice, et al.
Bone Marrow Transplantation|January 19, 2020
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centersThomas Hueso, Thomas Gastinne, Sylvain Garciaz, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomasAlberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, et al.
The New England Journal of Medicine|June 30, 2016
Midostaurin in Advanced Systemic MastocytosisMarie-Olivia Chandesris, Gandhi Damaj, Danielle Canioni, et al.
Pageof 18

Showing results (131-140 of 174) with videos related to

Sort By:
Pageof 18
Haematologica|February 9, 2019
A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failureMarie Sébert, Aline Renneville, Cécile Bally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized TrialsQian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.
Blood|May 24, 2015
Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosisStéphane Barete, Olivier Lortholary, Gandhi Damaj, et al.
The Lancet. Haematology|December 22, 2015
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trialAntonio Omuro, Olivier Chinot, Luc Taillandier, et al.
Annals of Hematology|April 11, 2023
Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission - a multi-center studyChristophe Desprez, Achille Kouatchet, Tony Marchand, et al.
Haematologica|October 3, 2015
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective studyJulien Lazarovici, Peggy Dartigues, Pauline Brice, et al.
Bone Marrow Transplantation|January 19, 2020
Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centersThomas Hueso, Thomas Gastinne, Sylvain Garciaz, et al.
Blood|August 12, 2011
Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use programMehdi Khellaf, Marc Michel, Philippe Quittet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomasAlberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, et al.
The New England Journal of Medicine|June 30, 2016
Midostaurin in Advanced Systemic MastocytosisMarie-Olivia Chandesris, Gandhi Damaj, Danielle Canioni, et al.
Pageof 18